Carborane‐Based Analogues of 5‐Lipoxygenase Inhibitors Co‐inhibit Heat Shock Protein 90 in HCT116 Cells
5‐Lipoxygenase converts arachidonic acid into leukotrienes, which are involved in inflammation and angiogenesis. The introduction of carboranes can improve the pharmacokinetic behavior of metabolically less stable pharmaceutics. Herein we report the syntheses of several carborane‐based inhibitors of...
Saved in:
Published in | ChemMedChem Vol. 14; no. 2; pp. 255 - 261 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Wiley Subscription Services, Inc
22.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | 5‐Lipoxygenase converts arachidonic acid into leukotrienes, which are involved in inflammation and angiogenesis. The introduction of carboranes can improve the pharmacokinetic behavior of metabolically less stable pharmaceutics. Herein we report the syntheses of several carborane‐based inhibitors of the 5‐lipoxygenase pathway. The isosteric replacement of phenyl rings by carboranes leads to improved cytotoxicity toward several melanoma and colon cancer cell lines. For the colon cancer cell line HCT116, the co‐inhibition of heat shock protein 90 was observed.
A tale of two targets: The functionalization of carboranes with tetrahydropyranyl and quinolinyl substituents leads to less potent 5‐lipoxygenase (5‐LO) inhibitors with significantly increased and selective cytotoxicity toward melanoma and colon cancer cells. The increased cytotoxicity was shown to be related to the simultaneous inhibition of 5‐LO and heat shock protein 90 (Hsp90). |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1860-7179 1860-7187 |
DOI: | 10.1002/cmdc.201800651 |